Plasma exchange and rituximab in the management of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus.

Damato, Erika

Plasma exchange and rituximab in the management of acute occlusive retinal vasculopathy secondary to systemic lupus erythematosus. [electronic resource] - Ocular immunology and inflammation Oct 2011 - 379-81 p. digital

Publication Type: Case Reports; Journal Article

1744-5078

10.3109/09273948.2011.603069 doi


Acute Disease
Adult
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Female
Fluorescein Angiography
Humans
Immunosuppressive Agents--therapeutic use
Lupus Vasculitis, Central Nervous System--complications
Methylprednisolone--therapeutic use
Mycophenolic Acid--analogs & derivatives
Neuroprotective Agents--therapeutic use
Plasma Exchange
Prednisolone--therapeutic use
Retinal Artery Occlusion--drug therapy
Retinal Vasculitis--therapy
Rituximab
Treatment Outcome
Visual Acuity--drug effects